SECTION 16 POWER OF ATTORNEY

      With  respect  to  holdings  of  and  transactions in securities issued by
Allergan  plc  (the  "COMPANY"), the undersigned hereby constitutes and appoints
the  individuals  named on SCHEDULE A attached hereto and as may be amended from
time to time, or any of them signing singly, with full power of substitution and
resubstitution, to act as the undersigned's true and lawful attorney-in-fact to:

      1. prepare,  execute  in  the  undersigned's name and on the undersigned's
         behalf,  and  submit  to  the  United  States  Securities  and Exchange
         Commission (the "SEC") a Form ID, including amendments thereto, and any
         other  documents  necessary  or appropriate to obtain and/or regenerate
         codes and passwords enabling the undersigned to make electronic filings
         with  the  SEC  of  reports required by Section 16(a) of the Securities
         Exchange Act of 1934, as amended, or any rule or regulation of the SEC;

      2. execute  for  and  on  behalf  of the undersigned, Forms 3, 4, and 5 in
         accordance  with  Section 16 of the Securities Exchange Act of 1934, as
         amended, and the rules thereunder;

      3. do  and  perform  any  and all acts for and on behalf of the
         undersigned which  may  be  necessary  or desirable to complete and
         execute any such Form  3,  4,  or  5,  complete  and  execute any
         amendment or amendments thereto,  and  timely file such form with the
         SEC and any stock exchange or similar authority; and

      4. take  any  other  action  of any type whatsoever in connection with the
         foregoing  which,  in  the  opinion of such attorney-in-fact, may be of
         benefit  to,  in  the  best  interest  of,  or legally required by, the
         undersigned,  it  being  understood that the documents executed by such
         attorney-in-fact on behalf of the undersigned pursuant to this Power of
         Attorney  shall  be  in  such  form  and  shall  contain such terms and
         conditions   as  such  attorney-in-fact  may  approve  in  his  or  her
         discretion.

      The undersigned hereby grants to each such attorney-in-fact full power and
authority  to  do  and perform any and every act and thing whatsoever requisite,
necessary,  or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could   do   if   personally  present,  with  full  power  of  substitution  and
resubstitution  or  revocation,  hereby  ratifying  and confirming all that such
attorney-in-fact,  or  such  attorneys-in-fact  substitute or substitutes, shall
lawfully  do  or  cause  to  be done by virtue of this Power of Attorney and the
rights and powers herein granted.

      The  undersigned  acknowledges  that  the  foregoing attorneys-in-fact, in
serving  in  such  capacity at the request of the undersigned, are not assuming,
nor is any Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934, as amended.

      This  Power  of  Attorney  shall remain in full force and effect until the
undersigned  is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's  holdings of and transactions in securities issued by the Company,
unless  earlier  revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

      IN  WITNESS  WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 10th day of July 2018.


                                        /s/ Nesli Basgoz
                                        ----------------------
                                        NAME: Nesli Basgoz
                                        TITLE:  Director



                                   SCHEDULE A

Individuals  Appointed  as  Attorney-in-Fact with Full Power of Substitution and
Resubstitution

   1.  A. Robert D. Bailey, EVP & Chief Legal Officer and Corporate Secretary
   2.  Matthew Walsh, EVP & Chief Financial Officer
   3.  James D'Arecca, SVP, Chief Accounting Officer - Global
   4.  Kira Schwartz, Assistant Secretary